These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1795319)

  • 1. The automated modified Russell viper venom time test for the lupus anticoagulant.
    Petri M; Nelson L; Weimer F; Anderson D; Darlington T; Corash L
    J Rheumatol; 1991 Dec; 18(12):1823-5. PubMed ID: 1795319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level.
    Petri M; Rheinschmidt M; Whiting-O'Keefe Q; Hellmann D; Corash L
    Ann Intern Med; 1987 Apr; 106(4):524-31. PubMed ID: 3103510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus.
    Somers E; Magder LS; Petri M
    J Rheumatol; 2002 Dec; 29(12):2531-6. PubMed ID: 12465147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar mechanism of various lupus anticoagulants.
    Exner T
    Thromb Haemost; 1985 Feb; 53(1):15-8. PubMed ID: 3922078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe bleeding due to acquired hypoprothrombinemia-lupus anticoagulant syndrome. Case report and review of literature.
    Vivaldi P; Rossetti G; Galli M; Finazzi G
    Haematologica; 1997; 82(3):345-7. PubMed ID: 9234588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of "lupus-type" anticoagulant using diluted Russell's viper venom time. Study of 16 patients].
    Pardo Vigo A; Oteyza JP; Blanco L; Correa MA; César J; Avello AG; Frade JG; Navarro JL
    Sangre (Barc); 1987; 32(2):231-5. PubMed ID: 3112970
    [No Abstract]   [Full Text] [Related]  

  • 8. Alteration in the laboratory profile of a lupus anticoagulant in a patient with non-Hodgkin's lymphoma.
    Moore GW; Kamat AV; Gurney DA; O'Connor O; Rangarajan S; Carr R; Savidge GF
    Clin Lab Haematol; 2004 Dec; 26(6):429-34. PubMed ID: 15596003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory identification of lupus anticoagulants using the combination of activated partial thromboplastin time and Russell's viper venom at two phospholipid concentrations.
    Akkawat B; Chantarangkul V; Rojnuckarin P; Juntiang J
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S451-8. PubMed ID: 12930024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Russell viper venom time (RVVT) test for investigation of lupus anticoagulant (LA).
    Favaloro EJ
    Am J Hematol; 2019 Nov; 94(11):1290-1296. PubMed ID: 31379004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lupus anticoagulant testing with optical end point automation.
    Luddington R; Scales C; Baglin T
    Thromb Res; 1999 Nov; 96(3):197-203. PubMed ID: 10588462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Danowski A; Kickler TS; Petri M
    J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assays for lupus anticoagulant: the sensitivity of different assays.
    Jain A; Dash S; Marwaha N; Deodhar SD; Sehgal S
    Med Lab Sci; 1991 Jan; 48(1):31-5. PubMed ID: 1905773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of lupus anticoagulant using a modified diluted Russell's viper venom time test].
    Sato K; Kagami K; Asai M; Nakashima N; Takamatsu J
    Rinsho Byori; 1995 Mar; 43(3):263-8. PubMed ID: 7745832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiphospholipid syndrome.
    Gezer S
    Dis Mon; 2003 Dec; 49(12):696-741. PubMed ID: 14679358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of antiphospholipid antibodies in lupus nephritis.
    Natejumnong C; Ruangkanchanasetr P; Aimpun P; Supaporn T
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S121-8. PubMed ID: 17044463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory testing for lupus anticoagulant (LA) in patients taking direct oral anticoagulants (DOACs): potential for false positives and false negatives.
    Favaloro EJ; Mohammed S; Curnow J; Pasalic L
    Pathology; 2019 Apr; 51(3):292-300. PubMed ID: 30665674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of lupus anticoagulant by means of dilute Russell's viper venom time is affected by oral anticoagulant therapy.
    Jouhikainen T
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):627-32. PubMed ID: 2133242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of recently described tests for detection of the lupus anticoagulant.
    Forastiero RR; Cerrato GS; Carreras LO
    Thromb Haemost; 1994 Nov; 72(5):728-33. PubMed ID: 7900080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the dilute Russell viper venom time (dRVVT): its importance and pitfalls.
    Triplett DA
    J Autoimmun; 2000 Sep; 15(2):173-8. PubMed ID: 10968905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.